Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 253, Issue 1-2, Pages 97-110Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0378-5173(02)00664-6
Keywords
naproxen; inclusion complex; polyvinylpyrrolidone; ultraviolet-visible absorption and emission spectroscopy; Fourier transform infrared spectroscopy
Categories
Ask authors/readers for more resources
The aim of this study was to investigate the effects of the presence of the water-soluble polymer polyvinylpyrrolidone K-25 (MW = 24,000 g/mol) on the complexation of the AINE naproxen, in its sodium salt form, with the beta-cyclodextrin. The data revealed that the polyvinyl pyrrolidone K-25 interacts with the drug as well as with the drug: beta-cyclodextrin inclusion complex. The polymer shows more affinity for the inclusion complex, K = (6.67 +/- 0.292) x 10(-5) M-1 than for the free drug, (2.08 +/- 0.208) x 10(-5) M-1. The presence of different proportions of polymer, in a range 0-1% (w/w) of polyvinyl pyrrolidone, does not increase the ability of drug-cyclodextrin complexation but important changes in the driving force of complex formation were detected, depending on the percentage of polyvinylpyrrolidone K-25 present. At low polymer concentrations, the complexation process is driven entropically, while at higher PVP proportions it is enthalpically favored. In the ternary system, polyvinylpyrrolidone K-25 partially or totally coats the drug:beta-cyclodextrin inclusion complex interacting with the beta-cyclodextrin (through hydrogen bonds), and with the naproxen. (C) 2002 Elsevier Science B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available